onatasertib
antengene,bms
['atg-008', 'hcc', 'antengene']
#qmportfolio (sehk: 6996) has presented five posters at 2023. the company has shared a range of encouraging results including the promising efficacy of atg-008 in patients with advanced #hbv+ hcc, especially those who had received cpis. 
Founded in 2006, Qiming is a leading China VC firm with $9.4 billion in capital raised. We invest in the T&C and healthcare industries.